Rare diseases
Investigational molecules
Locations
A study of SAR448851 with florquinitau (18F) to assess safety and effectiveness in early Alzheimer’s disease
GermanyStudy of MK-2214 to slow disease progression in people with early Alzheimer's disease
BelgiumStudy on Brain Imaging for Alzheimer's Disease Using Florquinitau (18F) in Patients with Mild Cognitive Impairment and Early Alzheimer's Symptoms
BelgiumComparison of Three PET Tau Tracers ([18F]RO948, [18F]PI2620, and [18F]MK-6240) in People with Cognitive Impairment
SpainStudy on How Florquinitau (18F) Affects Brain Circuits in Early Alzheimer's Disease Stages
BelgiumEfficacy and Safety of Trontinemab with [18F]MK-6240 in Cognitively Unimpaired Individuals at Risk for Alzheimer’s Disease
DenmarkStudy of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer's Disease
DenmarkA study testing trontinemab compared to placebo in patients with early Alzheimer's disease including mild cognitive impairment and mild dementia
DenmarkStudy on Lecanemab and Drug Combination for Patients with Early Onset Alzheimer's Disease Due to Genetic Mutation
GermanyStudy of BMS-986446 for Early Alzheimer's Disease Patients
BelgiumStudy on the Effectiveness and Safety of GSK4527226 in Patients with Early Alzheimer's Disease
FinlandStudy of BAN2401 (lecanemab) in people with early stage Alzheimer's disease to evaluate its effectiveness in preventing disease progression
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
